Pharmacology for Nurses

study guides for every class

that actually explain what's on your next test

Angiogenesis

from class:

Pharmacology for Nurses

Definition

Angiogenesis is the process of new blood vessel formation from pre-existing vasculature. It is a critical component in the growth and progression of solid tumors, as it provides the necessary oxygen and nutrients to support the rapidly dividing cancer cells.

congrats on reading the definition of Angiogenesis. now let's actually learn it.

ok, let's learn stuff

5 Must Know Facts For Your Next Test

  1. Angiogenesis is a hallmark of cancer, as it allows tumors to overcome the limitations of oxygen and nutrient diffusion.
  2. Tumor cells secrete pro-angiogenic factors, such as VEGF, to stimulate the formation of new blood vessels that supply the growing tumor.
  3. Inhibiting angiogenesis is a targeted approach in cancer therapy, as it can deprive the tumor of essential resources and prevent further growth.
  4. Antiangiogenic drugs, such as bevacizumab and sorafenib, work by blocking the signaling pathways that promote new blood vessel formation.
  5. Angiogenesis is also involved in the metastatic process, as new blood vessels provide a route for cancer cells to enter the circulatory system and spread to distant sites.

Review Questions

  • Explain the role of angiogenesis in the growth and progression of solid tumors.
    • Angiogenesis is a critical process for the growth and progression of solid tumors. As a tumor expands, the existing blood vessels are unable to provide sufficient oxygen and nutrients to support the rapidly dividing cancer cells. In response, the tumor cells secrete pro-angiogenic factors, such as VEGF, which stimulate the formation of new blood vessels. These new vessels supply the tumor with the necessary resources, allowing it to continue growing and potentially metastasize to other parts of the body.
  • Describe how antiangiogenic drugs work in the context of cancer therapy.
    • Antiangiogenic drugs, such as bevacizumab and sorafenib, work by inhibiting the signaling pathways that promote new blood vessel formation. These drugs target the key regulators of angiogenesis, such as VEGF, to prevent the tumor from establishing a sufficient blood supply. By depriving the tumor of essential oxygen and nutrients, antiangiogenic drugs can effectively slow down or even stop the growth and progression of the cancer. This targeted approach to cancer therapy has become an important component of modern oncological treatment strategies.
  • Analyze the relationship between angiogenesis and the metastatic process in cancer.
    • Angiogenesis not only supports the growth of the primary tumor but also facilitates the metastatic process. The new blood vessels formed during angiogenesis provide a route for cancer cells to enter the circulatory system and spread to distant sites in the body. As the tumor becomes more vascularized, it increases the likelihood of cancer cells breaking away and traveling through the bloodstream to establish secondary tumors at other locations. Therefore, the process of angiogenesis is a key factor in the metastatic spread of cancer, and inhibiting angiogenesis can be an effective strategy to prevent or slow down the metastatic progression of the disease.
© 2024 Fiveable Inc. All rights reserved.
AP® and SAT® are trademarks registered by the College Board, which is not affiliated with, and does not endorse this website.
Glossary
Guides